Infections
viral hepatitis, infections, Herpes zoster infection
INFECTIONS, VIRAL HEPATITIS, HERPES ZOSTER INFECTION, TUBERCULOSIS REACTIVATION, PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
37.1% of patients developed infections during the trial, with 8.4%, 14.4%, and 13.4% of patients experiencing mild, moderate, and severe infections, respectively. 17.9% of patients experienced infection-associated SAEs. Herpes zoster infection occurred in 4.7% of patients. There were no cases of viral hepatitis (new diagnosis or reactivation) or tuberculosis reactivation. One single case of progressive multifocal leukoencephalopathy was reported.